CanSino Biologics, Inc. Class H (HK:6185) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
CanSino Biologics Inc. has announced the composition of its board of directors, which includes Dr. Xuefeng YU as Chairman and Executive Director, alongside other executive, non-executive, and independent directors. The company also disclosed the structure of its three Board committees—Audit, Remuneration and Assessment, and Nomination—with details on each member’s committee roles.
For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.
